Von Hippel-Lindau Peptide Vaccine
A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein. (NCI04) [ ]
Term info
Von Hippel-Lindau Peptide Vaccine
- VHL Peptides
- VHL peptide vaccine
- Von Hippel-Lindau Peptide Vaccine
NCIT_C128784
Von_Hippel-Lindau_Peptide_Vaccine
900100
43154
Von Hippel-Lindau Peptide Vaccine
Pharmacologic Substance, Immunologic Factor
C0796336
C2492
Term relations
- Incomplete Freund's Adjuvant/Interleukin-2/Von Hippel-Lindau Peptide Vaccine
- Incomplete Freund's Adjuvant/Von Hippel-Lindau Peptide Vaccine
- Incomplete Freund's Adjuvant/Sargramostim/Von Hippel-Lindau Peptide Vaccine
- Montanide ISA-51/von Hippel-Lindau peptide vaccine
- Montanide ISA-51/Sargramostim/von Hippel-Lindau peptide vaccine
- Interleukin-2/Montanide ISA-51/Von Hippel-Lindau Peptide Vaccine